The aim of the study was to evaluate the risk factors and the incidence of comorbidity in patients with coronary heart disease, depending on the presence of atrial fibrillation.
Introduction
At present, atrial fibrillation (AF) is one of the most common forms of arrhythmias, which often leads to acute cerebrovascular disruption and has a negative social significance [1, 2] .
According to statistics, every fifth case of stroke is due to the presence of atrial fibrillation [3, 4] . In this case, ischemic strokes in this type of arrhythmias often have fatal consequences, and those surviving patients have consequences with severe disability [5] .
It is known, that spread of comorbidity is connected with age [6] . According to literature, with age, the prevalence of atrial fibrillation is also increasing: almost 10 % of people over the age of 80 undergo AF; for those who have reached the age of 94 this figure is up to 25 % [7, 8] . The study of risk factors and comorbidity in patients with atrial fibrillation of non-valvular genesis requires a detailed analysis, since it has clinical significance for the prevention and treatment of this category of patients.
Aim of the research
To evaluate the risk factors and the incidence of comorbidity in patients with ischemic heart disease, depending on the presence of atrial fibrillation.
Materials and methods of the research
A retrospective analysis of 222 histories of illnesses of patients with ischemic heart disease (IHD) undergoing in-patient treatment on the basis of the "Regional Clinical Hospital named after І. І. Mechnikov" during 2015-2016, aged from 39 to 88 years.
Depending on the presence of atrial fibrillation, all patients were divided into 2 groups: Group 1 (main) -patients with ischemic heart disease with atrial fibrillation (n=105). Group 2 (comparison) -patients with ischemic heart disease without atrial fibrillation (n=117). From all patients were collected anamnestic data, physical and laboratory-instrumental tests (clinical and biochemical blood tests, general urine analysis, electrocardiogram registration, radiography of the chest, ultrasound examination of the abdominal cavity). All patients were measured anthropometric data with the calculation of the body mass index (BMI) according to the standard formula [9] . To evaluate the function of the kidneys were performed the determination of creatinine and the calculation of glomerular filtration rate (GFR) according to the MDRD formula [10] according to the recommendations of the American National Federation of Nephrology [5, 10] . In order to evaluate the hemodynamic parameters, patients underwent pre-pleural cardiac examination of the heart using the standard method [9] . In the presence of indications, the patient was monitored with the Holter's method. The functional state of the thyroid gland was determined by the evaluation of thyroid hormones with the subsequent consultation of the endocrinologist.
For statistical processing of the research material, the following biostatistical methods were used: verification of the normality of the distribution of quantitative attributes in separate groups of comparison by the Shapiro-Wilka criterion; estimation of the reliability of the mean difference for quantitative signs with abnormal distribution by the Mann-Whitney criterion (U); correlation analysis with calculation of Spearman rank correlation coefficients (ρ). To describe the selective abnormal distribution of quantitative signs, the median (Me) and the interquartile scale (25 %, 75 %) were used. For the calculated relative values (P), the average error of the relative magnitude (mR) and 95 % confidence intervals were determined by the Wilson method with the correction for continuity. For the analysis of the relationships between different features, a correlation analysis was used to calculate the Spirman rank correlation coefficients (ρ) [11] .
The critical value of the statistical significance level when checking the null hypotheses was taken as 0.05 (5 %). When the value of p>0.05 was obtained, the difference between the indices was considered to be unreliable [12] .
Statistical processing of the results was performed using the STATISTICA 6.1 software (StatSoftInc., Serial number AGAR909E415822FA), Excel 2010, and the MedCalcStatistical Software trial version 17.4 software package. (MedCalcSoftwarebvba, Ostend, Belgium).
Results of the research
The general characteristics of the study groups are shown in Table 1 .
Since the abnormal distribution of quantitative signs was observed in the overwhelming majority (over 80 %) of indicators for describing the central trend of data, the median and the interquartile Me (25 %, 75 %) were used.
Analysis on the homogeneity of the study groups showed that there were no significant differences in the distribution of patients in groups depending on sex, anthropometric indicators (average height, weight, BMI), risk factors (heredity, smoking) (p>0.05), indicating their comparability and allows comparisons of other parameters.
The presence of statistically significant differences according to age characteristics was determined (p<0.001): in the group with AF, on average, older patients (average age 65.0 (59.0; 72.0)) compared with the group without AF (60.0 (53.0; 69.0)). The proportion of persons over the age of 60 in the main group is 68.57 %, in the comparison group -48.72 % (p=0.003). The inverse weak link between the presence of AF (group) and age is the Spearman correlation coefficient c=-0.23 (p<0.05).
The proportion of persons with BMI greater than 30 is higher in the group without atrial fibrillation (36.46 % versus 27.27 % in the AF group) without statistically significant differences.
In the group of patients without AF, the proportion of persons with inherited exacerbations of IHD was 64.29 %, while in the main group -25.0 %, the differences did not reach the statistically significant level, but this relationship is confirmed by the results of the rank correlation analysis -between the presence AF and heredity revealed a significant weak feedbackc= -0.21 (p<0.05).
The diseases observed in the examined patients with ischemic heart disease are acute stroke, angina pectoris, acute coronary syndrom (ACS), hypertension (HT), diabetes mellitus (DM), kidney and thyroid pathology, diastolic dysfunction (DD) and obesity ( Table 2) . The groups differed in the proportion of patients with acute stroke -in the group with AF, it was significantly (p=0.002) higher -23.81 %, compared with 8.55 % in the comparison group. Also, the differences were determined by angina -in the group without AF, the proportion of patients with coronary artery disease was higher and amounted to 58.97 %, whereas among patients with atrial fibrillation -31.43 % (p<0.001). The difference is mainly due to discrepancies in the presence of angina of the 3rd functional class -38.46 % in the group without AF and 20.95 % in the presence of atrial fibrillation (p=0.005).
Original Research Article: full paper (2018), «EUREKA: Health Sciences» Number 1 Patients with atrial fibrillation did not differ in the proportion of people with acute myocardial infarction -in general, 20.72 % with a minor excess in the comparison group (23.93 % vs. 17.14 %), hypertension (92.31 % in the group without AF, and 85.71 % in the AF group), diabetes mellitus (43.12 % and 39.22 % respectively), kidney pathology (67.65 % and 73.42 % respectively), obesity (48.48 % and 41.79 % % respectively).
In the structure of the distribution according to the HT stage, there were no discrepancies regarding the stage of the disease, and then differences were observed only in the proportion of patients with 3rd stage HT, which was higher in the comparison group (38.46 % in the group without AF with 23.81 % with atrial fibrillation).
It should be noted that there are significant differences (p=0.002) between the groups in the proportion of patients with obesity of the 2nd stage -the proportion of such patients is greater in the group without AF (5.97 %), compared with the group with AF (17.17 %).
The proportion of patients with diastolic dysfunction (DD) in the group without AF is significantly higher (69.9 %) compared with the group without AF -22.5 % (p<0.001).
Thyroid dysfunction was found in the main group with a frequency of 61.33 % (95 % CI 50.02-71.54), which is statistically significant (p<0.05) and can be compared more with the group without AF -46.23 % (95 % CI 37.03-55.68). In addition to the thyroid pathology, in the main group, the frequency of GPMC was significantly higher (p<0.05), significantly lower -the frequency of angina and DD (Fig. 1) . Table 2 Original Research Article: full paper
Continuation of
In the main study group, the incidence of concomitant pathology in the order of decline predominated: HT, kidney pathology and thyroid pathology; whereas in the comparison group -HT, diastolic dysfunction and kidney pathology. The last ranked place in the frequency of occurrence in the group with AF was acute myocardial infarction -17.14 % (95 % CI 11.13-25.48), while in the comparison group, the penultimate one with a frequency of 23.93 % (95 % CI 17, 11-32.41).
By rank correlation analysis, reliable (p<0.05) inverse correlation bonds of mean strength of AF with diastolic dysfunction (ρ=-0.43; p<0.001) were found; weak -with angina pectoris (ρ= = -0.28; p<0.001) and degree of GC (ρ= -0.20; p= 0.003). Consequently, in the presence of these diseases, atrial fibrillation develops less frequently. Direct weak correlations were detected between AF and acute stroke (ρ=0.21; p=0.002) and pathology of the thyroid gland (ρ=0.15; p=0.045), therefore, atrial fibrillation develops more frequently in these pathologies. 
Discussion
According to the results of numerous studies with age, increases the incidence of cardiovascular diseases such as hypertension, ischemic heart disease, heart failure, various cardiac arrhythmias, post-infarction cardiosclerosis [13, 15] .
The results of the study are consistent with the literature, which indicates that the presence of atrial fibrillation also increases with age [15, 16] . At the same time, according to modern ideas and results obtained, the incidence of atrial fibrillation and the frequency of comorbidity [17] increases with age, which greatly complicates the diagnosis and choice of therapeutic tactics when combined with a patient with comorbidity and atrial fibrillation [18] .
Nowadays, there are data on the relationship between body mass and the development of cardiovascular disease [19] . Some studies indicate that patients with high body weight have lower mortality in patients with heart failure than patients with low body weight [9, 20] . According to the European guidelines, in the presence of atrial fibrillation, the mass of the body may be a predictor of its development [7, 21] , which does not contradict the results. According to the study, the incidence rate of obesity was found to be rather high in both groups.
Identification at an early stage the diagnosis, the patient's risk factors and comorbid pathology is important for the primary prevention as well as for secondary prevention in order to prevent the development of repeated acute stroke, which often develop in this category of patients (2018), «EUREKA: Health Sciences» Number 1 [22, 23] . Development of individual practical recommendations for the diagnosis and treatment of atrial fibrillation in patients with ischemic heart disease, depending on the presence of comorbidity pathology [24] , which is planned in the future, has a promising value in practice.
6. Conclusions 1. The presence of atrial fibrillation in patients with coronary heart disease is associated with a high degree of comorbidity that increases with age.
2. In case of combination IHD and atrial fibrillation was detected a high incidence of hypertension, diabetes mellitus, obesity, acute cardiovascular disorders, kidney disease and thyroid gland.
